Protara Therapeutics, Inc. (TARA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Protara Therapeutics, Inc. (TARA) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

TARA Income Statement

Protara Therapeutics, Inc. (TARA) annual income statement — 14-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	90K	0	0	0	0	0	0	0	83K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-90K	0	0	0	0	0	0	0	-83K	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	100%	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	23.15M	23.32M	19.54M	19.08M	14.76M	16.59M	14.12M	14.31M	12.33M	10.66M	11.77M	11.04M	10.7M	12.14M	9.73M	39.51M	7.97M	8.71M	10.87M	10.29M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	6.35M	6.37M	6.07M	5.96M	5.17M	5.82M	4.98M	4.81M	4.26M	4.27M	4.1M	4.66M	4.48M	4.89M	4.59M	5M	4.51M	5.62M	5.61M	6.22M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	16.8M	16.95M	13.47M	13.12M	9.59M	10.77M	9.15M	9.5M	8.07M	6.39M	7.67M	6.38M	6.22M	7.25M	5.14M	4.99M	3.47M	3.08M	5.27M	4.07M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1000K	0	0	0	0
Operating Income	-23.15M	-23.32M	-19.63M	-19.08M	-14.76M	-16.59M	-14.12M	-14.31M	-12.33M	-10.66M	-11.85M	-11.04M	-10.7M	-12.14M	-9.73M	-39.51M	-7.97M	-8.71M	-10.87M	-10.29M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-56.87%	-40.62%	-38.98%	-33.31%	-19.71%	-55.58%	-19.18%	-29.63%	-15.23%	12.18%	-21.77%	72.05%	-34.19%	-39.46%	10.5%	-284.07%	26.37%	31.95%	19.93%	-14.86%
EBITDA	-23.15M	-23.25M	-19.54M	-18.99M	-14.67M	-16.49M	-14.04M	-14.23M	-12.25M	-10.58M	-11.77M	-10.93M	-10.62M	-12.06M	-9.65M	-39.43M	-7.91M	-8.65M	-10.82M	-10.23M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-57.81%	-41.02%	-39.16%	-33.42%	-19.81%	-55.87%	-19.32%	-30.14%	-15.3%	12.3%	-21.88%	72.27%	-34.27%	-39.41%	10.75%	-285.36%	22.01%	32.07%	20.15%	-15.08%
D&A (Non-Cash Add-back)	0	72K	90K	93K	88K	98K	83K	82K	84K	83K	83K	107K	79K	78K	77K	75K	64K	53K	56K	54K
EBIT	0	-21.67M	-17.78M	-17.31M	-13.26M	-14.96M	-11.91M	-12.77M	-11.22M	-9.51M	-11.1M	-10.22M	-10.7M	-12.14M	-9.73M	-9.99M	-7.42M	-8.19M	-10.35M	-8.31M
Net Interest Income	0	0	1.84M	1.5M	1.5M	1.61M	1.72M	1.15M	1.1M	1.14M	747K	814K	838K	842K	687K	525K	283K	166K	119K	59K
Interest Income	0	0	1.84M	1.5M	1.5M	1.61M	1.72M	1.15M	1.1M	1.14M	747K	814K	838K	842K	687K	632K	557K	512K	529K	59K
Interest Expense	1.47M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	107K	274K	346K	410K	-
Other Income/Expense	1.47M	1.66M	1.85M	1.77M	1.5M	1.63M	2.21M	1.54M	1.11M	1.15M	756K	820K	840K	846K	687K	542K	283K	166K	119K	59K
Pretax Income	-21.69M	-21.67M	-17.78M	-17.31M	-13.26M	-14.96M	-11.91M	-12.77M	-11.22M	-9.51M	-11.1M	-10.22M	-9.86M	-11.29M	-9.04M	-38.97M	-7.69M	-8.54M	-10.76M	-10.23M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-21.69M	-21.67M	-17.78M	-17.31M	-13.26M	-14.96M	-11.91M	-12.77M	-11.22M	-9.51M	-11.1M	-10.22M	-9.86M	-11.29M	-9.04M	-38.97M	-7.69M	-8.54M	-10.76M	-10.23M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-63.58%	-44.84%	-49.25%	-35.54%	-18.17%	-57.26%	-7.38%	-24.93%	-13.78%	15.77%	-22.66%	73.77%	-28.2%	-32.26%	15.9%	-280.98%	28.64%	33.2%	20.13%	-16.13%
Net Income (Continuing)	-21.69M	-21.67M	-17.78M	-17.31M	-13.26M	-14.96M	-11.91M	-12.77M	-11.22M	-9.51M	-11.1M	-10.22M	-9.86M	-11.29M	-9.04M	-38.97M	-7.69M	-8.54M	-10.76M	-10.23M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.35	-0.36	-0.31	-0.38	-0.31	-0.35	-0.29	-0.48	-0.50	-0.45	-0.97	-0.90	-0.87	-1.00	-0.74	-3.45	-0.66	-0.73	-0.95	-0.91
EPS Growth %	-12.9%	-2.86%	-6.9%	20.83%	38%	22.22%	70.1%	46.67%	42.53%	55%	-31.08%	73.91%	-31.82%	-36.99%	22.11%	-279.12%	31.25%	35.96%	20.83%	-16.67%
EPS (Basic)	-0.35	-0.36	-0.31	-0.38	-0.31	-0.35	-0.29	-0.48	-0.50	-0.45	-0.97	-0.90	-0.87	-1.00	-0.74	-3.45	-0.66	-0.73	-0.95	-0.91
Diluted Shares Outstanding	62.85M	61.01M	57.54M	46.04M	42.27M	42.27M	40.71M	26.43M	22.33M	21.23M	11.42M	11.36M	11.35M	11.31M	11.3M	11.27M	11.27M	11.26M	11.25M	11.24M
Basic Shares Outstanding	62.85M	61.01M	57.54M	46.04M	42.27M	42.27M	40.71M	26.43M	22.33M	21.23M	11.42M	11.36M	11.35M	11.31M	11.3M	11.27M	11.27M	11.26M	11.25M	11.24M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-